Answers are grounded in this paper and cite their sources.
NU6027 inhibits ATR, impairing G2/M arrest and homologous recombination thus increasing sensitivity to DNA-damaging agents and PARP inhibitors. It provides proof of concept data for clinical development of ATR inhibitors.
No takes yet. Share an insight, caveat, or question.
Peasland et al. (2011) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: